The Firm will likely be an Exhibitor at Kosherfest 2020 (Sales space # 4073), 10ft x 8ft Nook Sales space, November 10-11, 2020 @ Meadowlands Exposition Heart – Secaucus, New Jersey
NEW YORK, NY, July 02, 2020 (GLOBE NEWSWIRE) — through NEWMEDIAWIRE — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Firm”), a income producing, diversified life sciences Firm, with a proprietary line of practical “complement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) in addition to two ongoing Biotechnology initiatives, at the moment introduced that it has entered its Peach-Lemon taste Tauri-Gum™, Cannabigerol (“CBG”) infused model, into the upcoming 2020 Kosherfest “Finest New Product Competitors.” Moreover, the Firm will as soon as once more be a Company Exhibitor at Kosherfest 2020 – November 10-11, 2020 at Meadowlands Exposition Heart (Secaucus, New Jersey). Because of the Firm’s progress over the previous 12 months, when it comes to each income and product choices, the Firm has opted for a a lot bigger Exhibitor Sales space (# 4073) — 10ft x 8ft Nook Sales space — @ Kosherfest 2020.
The Firm’s proprietary CBG infused model of Tauri-Gum™ has been out there to clients, since Might 2020. The product is Kosher Licensed (Star-Ok), Vegan Formulated, All-Pure Taste(s), and NON-GMO.
ABOUT TAURIGA SCIENCES INC.
Tauriga Sciences, Inc. (TAUG) is a income producing, diversified life sciences firm, engaged in a number of main enterprise actions and initiatives. The corporate manufactures and distributes a number of proprietary retail merchandise and product traces, primarily targeted on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market section. The principle product line, branded as Tauri-Gum™, consists of a proprietary complement chewing gum that’s each Kosher licensed and Vegan formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate) & (CBG Infused Tauri-Gum™ Taste: Peach-Lemon). The Firm’s commercialization technique consists of a broad array of retail clients, distributors, and a fast-growing E-Commerce enterprise section (E-Commerce web site: www.taurigum.com). Please go to our company web site, for extra data, in addition to inquiries, at www.tauriga.com
Complementary to the Firm’s retail enterprise, are its two ongoing biotechnology initiatives. The primary one pertains to the event of a Pharmaceutical grade model of Tauri-Gum™, for nausea regulation (particularly designed to assist sufferers which can be subjected to ongoing chemotherapy therapy). On March 18, 2020, the Firm introduced that it filed a provisional U.S. patent utility overlaying its pharmaceutical grade model of Tauri-Gum™. The Patent, filed with the usP.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. The second pertains to a collaboration settlement with Aegea Biotechnologies Inc. for the co-development of a fast, multiplexed, Novel Coronavirus (COVID-19) take a look at with superior sensitivity and selectivity.
The Firm is headquartered in New York Metropolis and operates a regional workplace in Barcelona, Spain. As well as, the Firm operates a full time E-Commerce success middle situated in LaGrangeville, New York.
DISCLAIMER — Ahead-Wanting Statements
This press launch comprises sure “forward-looking statements” as outlined by the Personal Securities Litigation Reform Act of 1995 which symbolize administration’s beliefs and assumptions regarding future occasions. These forward-looking statements are sometimes indicated by utilizing phrases akin to “might,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and will embrace statements concerning company targets in addition to the attainment of sure company targets and milestones. Ahead-looking statements are primarily based on current circumstances and on administration’s current beliefs with respect to occasions that haven’t occurred, that will not happen, or that will happen with totally different penalties or timing than these now assumed or anticipated. Precise outcomes might differ materially from these expressed in ahead trying statements as a consequence of recognized and unknown dangers and uncertainties, akin to should not ensures of common financial and enterprise situations, the power to efficiently develop and market merchandise, shopper and enterprise consumption habits, the power to consummate profitable acquisition and licensing transactions, fluctuations in trade charges, and different components over which Tauriga has little or no management. Many of those dangers and uncertainties are mentioned in larger element within the “Threat Elements” part of Tauriga’s Kind 10-Ok and different filings made now and again with the Securities and Alternate Fee. Such forward-looking statements are made solely as of the date of this launch, and Tauriga assumes no obligation to replace forward-looking statements to replicate subsequent occasions or circumstances. You shouldn’t place undue reliance on these forward-looking statements.
Tauriga Sciences, Inc.
555 Madison Avenue, fifth Flooring
New York, NY 10022
Chief Government Officer
Mr. Seth M. Shaw
Electronic mail: firstname.lastname@example.org
cell # (917) 796 9926
Corp. Web site: www.tauriga.com
E-Commerce Web site: www.taurigum.com